CVB · ASX

Curvebeam AI Ltd. (ASX:CVB)

AU$0.11

 0.005 (4.762%)
ASX:Live
07/08/2025 12:14:18 PM
HALO Ords HALO Consensus Value GROWTH AUS Extreme Overbought All-Consensus +1
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

CVB Overview

CVB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Strong

Growth

Earnings

Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About CVB

Website

N/A

Telephone

N/A

Address

Description

CurveBeam AI Ltd. engages in the research, design, and manufacture of cone beam computed tomography imaging systems. The company was founded in September 2022 and is headquartered in Hatfield, PA.

CVB Price Chart

Key Stats

Market Cap

AU$40.98M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.06 - 0.24

Trade Value (12mth)

AU$6,867.00

1 week

23.53%

1 month

40%

YTD

-25%

1 year

-54.35%

All time high

0.53

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

-323.40%

Operating Cashflow

-$22m

Free Cash Flow Return

-57.50%

ROIC

-60.80%

Interest Coverage

-12.80

Quick Ratio

1.50

Other Data

Shares on Issue (Fully Dilluted)

363m

HALO Sector

Healthcare

Next Company Report Date

20-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

CVB Announcements

Latest Announcements

Date Announcements

30 July 25

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

30 July 25

Investor Presentation - Q4 FY25 Quarterly Update

×

Investor Presentation - Q4 FY25 Quarterly Update

25 July 25

Timing of Q4 Quarterly Results Investor Webinar

×

Timing of Q4 Quarterly Results Investor Webinar

04 July 25

Notification of cessation of securities - CVB

×

Notification of cessation of securities - CVB

03 July 25

Notification of cessation of securities - CVB

×

Notification of cessation of securities - CVB

10 June 25

Change in substantial holding from PNI

×

Change in substantial holding from PNI

30 April 25

Quarterly Appendix 4C Cash Flow Report

×

Quarterly Appendix 4C Cash Flow Report

30 April 25

Quarterly Activity Report - Q3 FY25

×

Quarterly Activity Report - Q3 FY25

30 April 25

Investor Presentation - Q3 FY25 Quarterly Update

×

Investor Presentation - Q3 FY25 Quarterly Update

24 April 25

Timing of Q3 Quarterly Results Release & Webinar

×

Timing of Q3 Quarterly Results Release & Webinar

09 April 25

Application for quotation of securities - CVB

×

Application for quotation of securities - CVB

08 April 25

CVB expects no material adverse effects from US tariffs

×

CVB expects no material adverse effects from US tariffs

07 April 25

Notification of cessation of securities - CVB

×

Notification of cessation of securities - CVB

04 April 25

Change of Director's Interest Notice - Rob Lilley

×

Change of Director's Interest Notice - Rob Lilley

04 April 25

Change of Director's Interest Notice - Arun Singh

×

Change of Director's Interest Notice - Arun Singh

03 April 25

Application for quotation of securities - CVB

×

Application for quotation of securities - CVB

31 March 25

Vendor Validation of Enhanced HiRise in Final Stages

×

Vendor Validation of Enhanced HiRise in Final Stages

25 March 25

Notification of cessation of securities - CVB

×

Notification of cessation of securities - CVB

20 March 25

Presentation at NWR Healthcare Conference

×

Presentation at NWR Healthcare Conference

28 February 25

Appendix 4D - Interim Financial Report - Dec 2024 Half Year

×

Appendix 4D - Interim Financial Report - Dec 2024 Half Year

28 February 25

CVB - Commentary to App 4D - Dec 24 Half Year

×

CVB - Commentary to App 4D - Dec 24 Half Year

04 February 25

Presentation at Euroz Hartleys 2025 Healthcare Forum

×

Presentation at Euroz Hartleys 2025 Healthcare Forum

29 January 25

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

29 January 25

Investor Presentation - Q2 FY25 Quarterly Update

×

Investor Presentation - Q2 FY25 Quarterly Update

28 January 25

Commercial Agreement with Stryker expanded to Aust & NZ

×

Commercial Agreement with Stryker expanded to Aust & NZ

CVB Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.03 -0.15 -0.08 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.03 -0.15 -0.08 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -499.2 49.2 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.02 -0.04 -0.05 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.02 -0.07 -0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -151.0 -16.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 0.0 -48.2 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock -0.03 -0.15 0.12 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock -0.03 -0.27 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -708.4 100.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 331 331 294 Lock Lock Lock
Basic m Lock Lock Lock Lock 331 331 294 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 0 8 7 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A -19.0 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 7 10 9 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 -8 -15 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -4,023.9 -80.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -104.0 -231.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 0 204 331 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -7 -17 -21 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -129.2 -25.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -209.2 -323.4 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 2 3 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -8 -19 -24 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -149.2 -27.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -233.8 -366.8 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -10 -53 -25 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 -2 -2 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -9 -51 -23 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -499.5 54.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -635.9 -353.9 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -8 -22 -22 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 1 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 -4 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 17 22 24 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -8 -22 -22 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -171.2 -0.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -2.7 -3.4 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 9 5 6 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 12 61 63 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 20 71 15 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 12 67 9 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 22 109 24 Lock Lock Lock
Equity $m Lock Lock Lock Lock -10 -48 39 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 10 23 53 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A 130.6 137.3 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -72.5 -83.5 -36.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 82.0 106.5 -59.4 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 0.0 -109.1 -60.8 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 0.0 -317.2 -60.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 0.0 -134.2 -57.5 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -2.8 -2.9 -12.8 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -1.7 -4.0 -0.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -118.5 -138.9 24.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 5.6 0.5 2.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 5.6 0.3 1.5 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 77.7 26.5 27.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -399.6 -55.8 -267.7 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 2.8 1.6 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.0 3.8 2.2 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.4 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 0.0 30.1 29.6 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.1 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.1 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 0.0 -654.8 -381.9 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 0.0 -86.0 -39.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -72.5 -83.5 -36.5 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock -1.1 -1.3 1.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 82.0 106.5 -59.4 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 82.0 106.5 -59.4 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.0 96.2 164.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 0.0 129.7 226.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 0.0 225.9 390.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 0.0 18.3 33.5 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 0.0 207.6 356.5 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

CVB Shortsell

Frequently Asked Questions

The current share price of Curvebeam AI Ltd. (CVB:ASX) is AU$0.11.
The 52-week high share price for Curvebeam AI Ltd. (CVB:ASX) is AU$0.24.
The 52-week low share price for Curvebeam AI Ltd. (CVB:ASX)? is AU$0.06.
Curvebeam AI Ltd. (CVB:ASX) does not pay a dividend.
Curvebeam AI Ltd. (CVB:ASX) does not pay a dividend.
Curvebeam AI Ltd. (CVB:ASX) has a franking level of 0.0%.
Curvebeam AI Ltd. (CVB:ASX) is classified in the Healthcare.
The current P/E ratio for Curvebeam AI Ltd. (CVB:ASX) is .
The current share price of Curvebeam AI Ltd. (CVB:ASX) is AU$0.11.
The 52-week high share price for Curvebeam AI Ltd. (CVB:ASX) is AU$0.24.
The 52-week low share price for Curvebeam AI Ltd. (CVB:ASX)? is AU$0.06.
Curvebeam AI Ltd. (CVB:ASX) does not pay a dividend.
Curvebeam AI Ltd. (CVB:ASX) does not pay a dividend.
Curvebeam AI Ltd. (CVB:ASX) has a franking level of 0.0%.
Curvebeam AI Ltd. (CVB:ASX) is classified in the Healthcare.
The current P/E ratio for Curvebeam AI Ltd. (CVB:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.